Compare FUTU & ALGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FUTU | ALGN |
|---|---|---|
| Founded | 2011 | 1997 |
| Country | Hong Kong | United States |
| Employees | N/A | N/A |
| Industry | Investment Bankers/Brokers/Service | Industrial Specialties |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.6B | 12.7B |
| IPO Year | 2018 | 2000 |
| Metric | FUTU | ALGN |
|---|---|---|
| Price | $96.11 | $161.37 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 12 |
| Target Price | ★ $217.75 | $199.82 |
| AVG Volume (30 Days) | ★ 5.5M | 890.6K |
| Earning Date | 05-28-2026 | 04-29-2026 |
| Dividend Yield | ★ 3.39% | N/A |
| EPS Growth | N/A | ★ 0.53 |
| EPS | N/A | ★ 1.57 |
| Revenue | N/A | ★ $387,126,000.00 |
| Revenue This Year | $27.96 | $5.78 |
| Revenue Next Year | $11.89 | $4.62 |
| P/E Ratio | ★ $17.05 | $106.17 |
| Revenue Growth | N/A | ★ 23.95 |
| 52 Week Low | $80.50 | $122.00 |
| 52 Week High | $202.53 | $208.31 |
| Indicator | FUTU | ALGN |
|---|---|---|
| Relative Strength Index (RSI) | 29.88 | 41.89 |
| Support Level | $80.50 | $153.68 |
| Resistance Level | $172.56 | $167.02 |
| Average True Range (ATR) | 7.36 | 6.17 |
| MACD | -2.29 | 0.82 |
| Stochastic Oscillator | 23.73 | 35.76 |
Futu Holdings Ltd is an online broker providing one-stop online investing services.. Through its proprietary digital platforms, Futubull and Moomoo, the Company provides a full range of investment services, including trade execution and clearing, margin financing and securities lending, and wealth management. The Group engages in online brokerage services and margin financing services. It generates its revenue in the form of brokerage commission and handling charge services, and interest income. Geographically, it operates in Hong Kong, which derives key revenue and it also has its presence in other countries.
Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients' teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans, and iTero scans make up over half of these scans.